| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |